Return to top of page

FDA/AD Allies Meeting on Combination Therapy Development


November 29, 2012
7:30 AM – 2:00 PM ET


Hilton Executive Meeting Center, 1750 Rockville Pike Rockville, MD 20852
Rockville, MD


To address critical issues in the development of new Alzheimer’s disease treatments, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) coalition and the Critical Path Institute will co-host the fifth-annual FDA/AD Allies Meeting. This annual meeting sponsored by ACT-AD brings together leaders in Alzheimer’s drug development from the patient advocacy community, federal health and regulatory agencies, academic research, and the private sector for focused discussions on key issues surrounding the development and regulation of Alzheimer’s drugs and therapies.

Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches were established to identify necessary pathways and tools that enabled more efficient trials. Our primary goal is to explore how similar partnerships could foster more robust collaboration in Alzheimer’s disease (AD) in order to encourage the development of combination therapies.

FDA has published draft guidance on the co-development of multiple treatments for use in combination. This meeting will allow stakeholders to gain greater clarity of FDA’s requirements for the development of multiple therapies in combination for the treatment of Alzheimer’s disease and explore the feasibility of practically designing clinical trials for more than one AD therapy.

Living Longer and Loving It

Sign up for our monthly e-mail newsletter for the latest information on
scientific research on aging and health.

Ways to Give

There are many ways you can help accelerate the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health:

Platinum Transparency 2024 logo

The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.

Charity Navigator Four-Star Rating Badge

The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.